IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Senti Biosciences Inc (SNTI)

CUSIP: 81726A209 | NYSE | Healthcare · Biotechnology | Micro Cap | 33 institutional holders

Quarters

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13D/ANew Enterprise Associates 15, L.P.3,775,61512.1%New 5%+ stakeMar 27, 2026No 13F filer matched
13D/ACeladon Partners, LLC13,511,32245.0%New 5%+ stakeJan 19, 2026

Institutional Holders — Q2 2026

NEA Management Company, LLC3,775,615
0.3% of portfolio›$4.2M
StyleTurnoverLocationFiled
NEA Management Company, LLC
3,775,615$4.2M0.3%Deep ValueLowTimonium, MD2026-08-14
No 13F filer matched
13D/ANew Enterprise Associates 15, L.P.3,775,615
12.1% of class · Mar 27, 2026New 5%+ stake
No 13F filer matched
13D/ACeladon Partners, LLC13,511,322
45.0% of class · Jan 19, 2026New 5%+ stake
No 13F filer matched